admin

Post-pandemic, the global bio-pharmaceutical sector, often overlooked, presents undervalued opportunities, notably in blue-chip stocks like Pfizer (NYSE:PFE). Following a 42% correction in the past year, PFE stock, with a 5.84% dividend yield, appears promising for 2024. The company anticipates $60 billion in revenue, signaling 9% year-on-year growth, supported by a compelling product pipeline. Here are
0 Comments
The shares of battery maker QuantumScape (NYSE:QS) rocketed higher earlier this month on news that its solid-state battery can be charged over 1,000 times without degrading. Unfortunately for the long-term outlook of QS stock, this characteristic, while certainly positive, does not address the main “pain points” facing drivers and automakers. Moreover, QS has at least
0 Comments
Calling all income investors to witness the magic of dividends—a powerful force in minimizing portfolio risk and volatility. These payouts not only offset stock losses but also bring a satisfying reward for having a stake in a company. Amid the Federal Reserve’s persistent battle against inflation, any hopes for a “Fed pivot” remain distant. High-interest
0 Comments
Today, identifying investments with promising growth potential is a quest every investor undertakes. Within the loud noises of the stock market, three standout companies are making waves. Their strategies and innovations forecast substantial gains, promising a 2X capital level by 2025. The first one on the list is a pioneer in digital payments, emphasizing enhanced
0 Comments
Palantir Technologies (NYSE:PLTR) has deals with both private businesses and government entities. The company is a redoubtable force in cyber-defense but also enhanced its products/services with artificial intelligence technology. As we look into the new year for long-term picks, Palantir Technologies is a high-conviction tech company and PLTR stock earns a confident “B” grade. This doesn’t
0 Comments